about
Toward unraveling the complexity of simple epithelial keratins in human diseaseUpdated overview of current biomarkers in head and neck carcinomaOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionProteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation.Pediatric Osteosarcoma: An Updated ReviewHepatitis B virus infection and intrahepatic cholangiocarcinoma.Epithelial to mesenchymal transition and breast cancer.Multifunctional substrate of label-free electrochemical immunosensor for ultrasensitive detection of cytokeratins antigen 21-1.Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer.Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey.Tissue polypeptide antigen & interleukin-6: Are their serum levels a predictor for response to chemotherapy in breast cancer?Pharmacodynamic modelling of biomarker data in oncology.Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.Tumor markers in biological fluids associated with pregnancy.Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.Methodical and pre-analytical characteristics of a multiplex cancer biomarker immunoassay.The human keratins: biology and pathology.Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.Surface-affinity profiling to identify host-pathogen interactions.Differential diagnosis of pleural mesothelioma using Logic Learning Machine.Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.Serum tumor markers in pediatric osteosarcoma: a summary review.Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines.Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinomaCan widely used cell type markers predict the suitability of immortalized or primary mammary epithelial cell models?Biomarker method validation in anticancer drug developmentContinuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancerMethod validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cellsIncreased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer.Intermediate filament cytoskeleton of the liver in health and diseaseThe assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis.Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.A Pilot Study of CK19, CK20 and GCC mRNA in the Peripheral Blood as a Colorectal Cancer Biomarker PanelCirculating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression.A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions
P2860
Q24657673-4AB95B30-D91B-4B81-92DF-8A3883E0AEA0Q26750659-9C9407E1-26AA-4A06-8651-929931AEC109Q28483701-13AD4876-4674-4759-8C40-E391B16D171DQ33415671-C376C6B1-F546-4099-B350-022E93B095EFQ33583291-04952009-78FD-4770-9016-4A23395F561DQ33626806-4A004DA7-7BFF-40A1-B946-DF3D91099F6AQ33627118-88DDC851-78F8-4E92-8C09-D8C9E1B35B3EQ33682664-549DDE41-F6C5-4703-9B08-927A53934B0BQ33875300-BB66A36C-33B5-4F50-A55E-D5E7311943DFQ34031517-4B04326B-FA2B-4410-B143-ACB11E7187BDQ34176287-B41A3828-0EF2-45EA-BAC5-B6710BFA61ECQ34241935-3E7DD615-66EC-403D-94DA-CCEFB1F9C252Q34330122-FB441F94-E9C0-48B7-9821-3E0BF24A1113Q34609148-56762177-B3E4-452A-88AA-1541E1924AAAQ34744836-F771988C-F385-46C1-9075-77DD34DB3B02Q34761258-D9B72E68-D98E-4F37-BE57-30DDCA3604E8Q34776574-449E7DB1-0D8C-4A0F-B9F0-DFDED4DE5240Q35123891-87893368-0F73-49C2-8B08-020386A802BFQ35598022-4EA94620-E9C8-43F2-9C43-5D5668180D56Q35655686-59FF6D5D-545B-4AAC-AAD2-DCA409330A36Q35863163-925AAFA0-3A1A-498A-BF4B-089901B73D0DQ35909576-7AF9EBAA-587A-4BEC-BAB5-AA16B94C349FQ35958288-CA581A4A-D53D-431D-91AE-FA68FB081F00Q35984687-23C69631-3FB1-4388-852C-765E2CC4851EQ36057627-D48674ED-2770-4D86-B0BF-7269ED6029EDQ36260567-117FD0FF-60DD-4AAE-8212-0DCD684297CAQ36375396-47D972EB-D164-44D4-975A-37011DF576A0Q36433437-A727FD2F-FB8E-4DB7-B4ED-8AFB2AE6ABCCQ36484621-91BF7C07-F915-4903-8A3F-5B28E8C36665Q36559818-AAC35048-3FC1-43D0-8208-A706D993D499Q36611534-157FD63D-9A08-4192-AC9F-D09082638019Q36611780-158FCCC0-4FD5-4993-8D84-D1A12AAB50EAQ36630663-BE7C90D2-C329-456D-8678-D4182E49D49BQ36661678-DA60A060-D387-4D81-A306-4EA7156DD84CQ36827736-F5967771-C5E3-4603-ADD5-DFFE2D933624Q36925400-6CBB01DF-156C-4E9E-932C-E3A839F5C6AAQ36985178-6291057A-2B2B-49DD-9D8E-07862AB9B56CQ37028135-CBFD8946-6309-487D-8B1F-CC24803DCC89Q37111059-6E32E45B-F512-48E7-88B4-9859A94E0F0CQ37112709-1C6552EC-8CF8-46A3-9D2F-92D94F73659F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical utility of cytokeratins as tumor markers.
@ast
Clinical utility of cytokeratins as tumor markers.
@en
type
label
Clinical utility of cytokeratins as tumor markers.
@ast
Clinical utility of cytokeratins as tumor markers.
@en
prefLabel
Clinical utility of cytokeratins as tumor markers.
@ast
Clinical utility of cytokeratins as tumor markers.
@en
P2093
P1476
Clinical utility of cytokeratins as tumor markers.
@en
P2093
Helena Goike
Katja W Panaretakis
Roland Einarsson
Vivian Barak
P304
P356
10.1016/J.CLINBIOCHEM.2004.05.009
P577
2004-07-01T00:00:00Z